Construction of bromodomain-containing protein 4 gene knockout mice by CRISPR/Cas9 combined with Cre-loxP technology

doi:10.12307/2022.892

Abstract

Abstract: BACKGROUND: Currently, the combined use of CRISPR/Cas9 and CRE-LOXP to prepare bromodomain-containing protein 4 (BRD4) gene knockout mice is very rare.
OBJECTIVE: To construct a BRD4 gene knockout mouse model by using CRISPR/Cas9 technology combined with Cre-loxP technology that can be used to knock out the BRD4 gene fragment in the mouse genome.
METHODS: According to the exon sequence of BRD4 gene, a gRNA was designed and synthesized. After gRNA was transcribed in vitro, Cas9 mRNA and plasmid containing loxp site were injected into fertilized oocytes. Cas9 cut the target fragment by recognizing the leading strand of the gRNA, and then loxp was inserted into the cleavage site. After breeding with Cre, the Cre enzyme cut the loxp site to achieve the final specific deletion effect. The fertilized oocytes were transplanted into C57BL/6N recipient female mice to obtain progeny mice. The offspring mice were sequenced to identify their genotypes. The BRD4-loxP +/- (F0 generation) mice with loxp loci being successfully introduced was bred with wild-type C57BL/6N mice, and the stably inherited mice BRD4-loxP +/- (F1 generation) were selected. Some of the BRD4-loxP +/- mice interbred with each other and some interbred with CAGGcre-ERTM mice. BRD4-loxP +/+ mice were co-expressed with BRD4-loxP+/- and CAGGcre-ERTM mice (F2 generation). The F2 generation mice were bred to obtain homozygous BRD4-loxP +/+ and CAGGcre-ERTM mice. BRD4 gene knockout was induced by intraperitoneal injection of tamoxifen (75 mg/kg, dissolved in corn oil) in 6-8 weeks homozygous mice for 7 consecutive days. DNA was extracted from the tail fragment of the knockout mice using adsorption column method. The expression of BRD4 gene fragment in mouse tail tissue was detected by agarose gel electrophoresis.
RESULTS AND CONCLUSION: Screening using PCR revealed that mice 7, 8, 9, 10, 12, 14, 16, 19, 20, 21, 25, 42, 43, and 47 of F1 generation were identified as heterozygous mice that were successfully inserted with two alleles of loxP fragment. The F3 homozygotes bred from F2 generation were induced with tamoxifen, and PCR gel electrophoresis verified that the BRD4 gene fragment was successfully knocked out in the homozygous mice. We therefore successfully constructed BRD4 gene knockout mice using CRISPR/Cas9 technology combined with CRE-LOXP technology in this study.

Key words: CRISR/Cas9, Cre-loxP, BRD4, gene knockout, mouse, tamoxifen

CLC Number:

Wang Xiangyu, Zhu Ruizhi, Zhao Zhiping, Zhang Yuda, Zhang Yongtao, Wang Changyao. Construction of bromodomain-containing protein 4 gene knockout mice by CRISPR/Cas9 combined with Cre-loxP technology[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(32): 5179-5184.

Figures/Tables 3

References

[1] DEY A, NISHIYAMA A, KARPOVA T, et al. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell. 2009;20(23):4899-4909.
[2] TANIGUCHI Y. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins. Int J Mol Sci. 2016;17(11):1849.
[3] LOVÉN J, HOKE HA, LIN CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320-334.
[4] ZUBER J, SHI J, WANG E, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478(7370): 524-528.
[5] DELMORE JE, ISSA GC, LEMIEUX ME, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011;146(6):904-917.
[6] BAUD’HUIN M, LAMOUREUX F, JACQUES C, et al. Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis. Bone. 2017;94:10-21.
[7] 任远中. BRD4在类风湿性关节炎骨破坏中的作用机制研究[D]. 青岛:青岛大学,2020.
[8] NAJAFOVA Z, TIRADO-MAGALLANES R, SUBRAMANIAM M, et al. BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire. Nucleic Acids Res. 2017;45(1):127-141.
[9] MENG S, ZHANG L, TANG Y, et al. BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction. J Dent Res. 2014;93(7):657-662.
[10] MU J, ZHANG D, TIAN Y, et al. BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo. J Mol Cell Cardiol. 2020;149:1-14.
[11] LI W, TENG F, LI T, et al. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol. 2013;31(8):684-686.
[12] YANG H, ANG H, SHIVALILA CS, et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell. 2013;154(6):1370-1379.
[13] DOUDNA JA, CHARPENTIER E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (New York, N.Y.). 2014; 346(6213):1258096.
[14] 何晓东, 李江超, 兰天, 等. 乳腺上皮细胞特异性敲除Scrib基因杂合子小鼠的制作与鉴定[J]. 中国比较医学杂志,2013,23(6):28-32.
[15] AUBREY BJ, KELLY GL, KUEH AJ, et al. An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep. 2015;10(8):1422-1432.
[16] FLEMR M, BÜHLER M. Single-Step Generation of Conditional Knockout Mouse Embryonic Stem Cells. Cell Rep. 2015;12(4):709-716.
[17] NOIMAN T, KAHANA C. A Simple Combined Use of CRISPR-Cas9 and Cre-LoxP Technologies for Generating Conditional Gene Knockouts in Mammalian Cells. CRISPR J. 2018;1:278-285.
[18] GHOSH K, VAN DUYNE GD. Cre-loxP biochemistry. Methods (San Diego, Calif.). 2002;28(3):374-383.
[19] BOUABE H, OKKENHAUG K. Gene targeting in mice: a review. Methods Mol Biol (Clifton, N.J.). 2013;1064:315-336.
[20] 张杨, 贾林涛, 闫雨冬, 等. Cre-loxP系统及其衍生系统方法学的研究和在神经科学中的应用[J]. 药学学报,2020,55(9):2035-2042.
[21] FEIL R, WAGNER J, METZGER D, et al. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun. 1997;237(3):752-757.
[22] MA Y, YU L, PAN S, et al. CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre-loxP-mediated lineage tracing. FEBS J. 2017;284(19):3262-3277.
[23] HUANG, FL, LI F ZHANG WJ, et al. Brd4 participates in epigenetic regulation of the extinction of remote auditory fear memory. Neurobiol Learn Mem. 2021;179:107383.
[24] HENRY SP, JANG CW, DENG JM, et al. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis (New York, N.Y. : 2000). 2009;47(12):805-814.
[25] COUMOUL X, DENG CX. Roles of FGF receptors in mammalian development and congenital diseases. Birth Defects Res C Embryo Today. 2003;69(4):286-304.
[26] FRIEDBERG EC, MEIRA LB. Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7. DNA Repair (Amst). 2006;5(2):189-209.
[27] LE Y, SAUER B. Conditional gene knockout using cre recombinase. Methods Mol Biol (Clifton, N.J.). 2000;136:477-485.
[28] WEINSTOCK A, GALLEGO-DELGADO J, GOMES C, et al. Tamoxifen activity against Plasmodium in vitro and in mice. Malar J. 2019;18(1): 378-378.
[29] 仝慧慧, 齐浩铭, 王辰, 等. CRISPR/Cas9系统介导Slc6a6基因敲除大鼠的繁殖与鉴定[J]. 中国比较医学杂志,2019,29(5):44-50.
[30] DONATI B, LORENZINI E, CIARROCCHI A. BRD4 and Cancer: going beyond transcriptional regulation. Mol Cancer. 2018;17(1):164.
[31] WU SY, LEE CF, LAI HT, et al. Opposing Functions of BRD4 Isoforms in Breast Cancer. Mol Cell. 2020;78(6):1114-1132.e10.
[32] LIN S, DU L. The therapeutic potential of BRD4 in cardiovascular disease. Hypert Res. 2020;43(10):1006-1014.
[33] WANG H, FU H, ZHU R, et al. BRD4 contributes to LPS-induced macrophage senescence and promotes progression of atherosclerosis-associated lipid uptake. Aging. 2020;12(10):9240-9259.
[34] KIM SY, ZHANG X, SCHIATTARELLA GG, et al. Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function. Circulation. 2020;142(24):2356-2370.
[35] DEY A, YANG W, GEGONNE A, et al. BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses. EMBO J. 2019;38(7):e100293.
[36] XIAO Y, LIANG L, HUANG M, et al. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IkappaB kinase-dependent NF-kappaB activation in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford). 2016; 55(1):173-184.
[37] ZHANG QG, QIAN J, ZHU YC. Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis. Immunol Lett. 2015;166(2): 103-108.
[38] 许颖华, 姜龙, 史春. 慢性根尖周炎模型大鼠表观遗传分子：溴结构域蛋白4的表达变化[J]. 中国组织工程研究,2022,26(14):2167-2171.
[39] REN Y, ZHANG Y, WANG Z, et al. Role of Brd4 in the production of inflammatory cytokines in mouse macrophages treated with titanium particles. Can J Physiol Pharmacol. 2019;97(11):1028-1034.
[40] GUO NH, ZHENG JF, ZI FM, et al. I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma. Biosci Rep. 2019;39(5):BSR20181245.